Trulicity ® (dulaglutide) injection

0.75 mg/0.5 mL, 1.5 mg/0.5 mL

For questions regarding this product, please see: Full Prescribing Information

The below information is provided in response to your request and may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above.

TRULICITY® (dulaglutide): Formulation

The formulation of Trulicity (dulaglutide) consists of dulaglutide 1.5 mg or dulaglutide 0.75 mg in a solution with several other components.

US Medical letter template_09_Oct_2013

Trulicity® (dulaglutide) is a clear, colorless, sterile solution. Each 0.5 mL of dulaglutide solution contains 1.5 mg of dulaglutide or 0.75 mg of dulaglutide. Each single-dose pen contains 0.5 mL of solution and the following excipients: citric acid anhydrous (0.07 mg), mannitol (23.2 mg), polysorbate 80 (0.10 mg), and trisodium citrate dihydrate (1.37 mg) in water for injection (Trulicity Package Insert, 2017).

Enclosed Prescribing Information

TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly

Reference

Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2017.

Additional related information

Date of Last Review: April 12, 2017

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 8pm ET

Or you can

Ask us a question Chat with us

Submit a question

Visit Us @LillyMedical